Clinical Trial

Visuospatial and Affective Abilities in Parkinson Disease

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The aim of the study is to investigate whether prismatic adaptation (PA) and virtual prismatic adaptation (VPA), a non-invasive neuromodulation technique, that involves the use of lenses that deviate the visual field, can modulate alexithyima and performance in visuospatial tasks in patients with Parkinson disease. Furthermore, brain activity during the prismatic adaptation and post-adaptation phases will be recorded using functional near-infrared spectroscopy (fNIRS) and high-density electroencephalography (HD-EEG). Based on these premises, the present project aims to investigate the deficits of the affective, motor and visuospatial abilities in Parkinson's patients and the modulation of disorders through prismatic adaptation (PA) and virtual prism adaptation (VPA). Finally, we would like to evaluate production of the tear film and correlate their quantity with the severity of PD as it could be proposed as a new, non-invasive biomarker.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-03-26; most recent amendment 2026-02-23.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-02-23
Trial Details
NCT Number NCT06341829
Lead Sponsor IRCCS Centro Neurolesi Bonino Pulejo
Conditions Parkinson Disease, Alexithymia, Visuospatial/Perceptual Abilities
Enrollment 126 participants
Start Date 2024-04-30
Primary Completion 2024-05-01 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-02-24